IMO, CDX-1127 is a dud and sellside firms are pushing this compound to drum up a good story (immunotherapy) and drum up trading revenues. Sellside firms are now claiming CDX-1127 will be a great combo drug for PD1 (meanwhile, no one has seen any data on it, and I have heard zero buzz on the CD27 target from any science folks).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.